From June 25th to 28th, the 2024 MISI Conference (Pharmaceutical and Health Industry Symbiosis Conference) with the theme of "Renjin and New Bureau" was held in the South Taihu Longemont Diamond Conference Center.
The conference gathered more than 5,000 industry elites, including leaders of various government associations, experts and scholars, the top 100 chain pharmacies in China, terminals inside and outside the hospital, major innovative pharmaceutical companies, and mainstream media inside and outside the industry, as official representatives to share professional knowledge, discuss the development of innovative models, promote the docking and cooperation of resources and technologies in the whole industry chain, and lead the industry to continuously upgrade and innovate.
At the meeting, Suzhou Lezhu Pharmaceutical Co., Ltd. (formerly Suzhou Industrial Park Tianlong Pharmaceutical Co., Ltd.) made a strong appearance with its full line of ophthalmic products, and once again ranked on the list of retail terminals of China's pharmaceutical brands with its star product Lezhu ® Pearl Eye Drops (colloidal solution).
It's very popular! The core categories shine brightly
Located in F-6, Lezhu Pharmaceutical's booth was carefully planned and arranged, displaying five core ophthalmic products: anti-eye fatigue, dry eye treatment, antibacterial and anti-inflammatory, anti-glaucoma, and anti-allergies. With professional knowledge and enthusiasm, the staff of Lezhu Pharmaceutical patiently answered every visitor's questions and introduced the characteristics and advantages of the product in detail.
Glory continues! Star products have been on the list for three times
On the evening of June 27, the exciting 2024 China Pharmaceutical Brand List Release Ceremony was held in the CDE Hall on the first floor of the Diamond Convention Center. Lezhu ® Pearl Eye Drops (colloidal solution) lived up to expectations and appeared on the list again!
Suzhou Lezhu Pharmaceutical Co., Ltd. has a deep relationship with Misihui. Since the brand's debut in 2019, Lezhu ® eye drops have successfully entered the brand list with excellent product quality and strong brand influence. Since then, Lezhu Pharmaceutical has continued to improve, and in 2023, it will once again be on the list of Chinese pharmaceutical brands (retail terminals). Now, this is the third time that Lezhu ® eye drops have been on the brand list!
It has been on the list for many times, which is not only a full embodiment of the quality and brand value of Lezhu ® eye drops, but also a strong proof of Lezhu Pharmaceutical's profound strength and unremitting efforts in the field of ophthalmology.
Attached is part of the list of 2024 China Pharmaceutical Brand List [Retail Terminal].
Lezhu ® Pearl Eye Drops (colloidal solution) is an exclusive product in China, which is an original addition of sodium hyaluronate to Pearl Eye Eye Drops, making it a slow-release eye drop. The innovative formula of pearl liquid + borneol + sodium hyaluronate brings together three effective eye protection ingredients, clears away heat and fire, nourishes the liver and eyes, and effectively treats visual fatigue and chronic conjunctivitis, which is deeply loved by consumers.
With its excellent product efficacy and good performance in the terminal market, Lezhu has won many honorary titles such as the selected brand of OTC Brand Promotion Month, the sharp list of "China Pharmaceutical Brand List", the most promising new varieties of the year, the standing medicine of Chinese families, and the most popular star single product of chain pharmacies for many years.